| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/16/2002 | WO2002038103A2 Probiotic compositions and methods against bacterial infection in livestock animals |
| 05/16/2002 | WO2002037968A1 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 05/16/2002 | WO2002006502A3 Adenovirus vectors comprising introns |
| 05/16/2002 | WO2001088105A3 Production of dendritic cells from bone-marrow stem cells |
| 05/16/2002 | WO2001088098A3 Fertilization of aged oocytes |
| 05/16/2002 | WO2001079518A3 Codon optimisation for expression in retrovirus packaging cells |
| 05/16/2002 | WO2001058526A3 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032685A8 Gene expression directed by a super-psa promoter |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | US20020059652 Detecting modulators of liver cell propagation, cell differentiation and lymphocyte activity; obtain modulator, incubate with indicator, mix with culture monitor culture for adjustment in activity |
| 05/16/2002 | US20020058983 Methods for implanting cells |
| 05/16/2002 | US20020058636 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 05/16/2002 | US20020058326 Microorganism for use in the diagnsis of cancer and treatment of lactase defect |
| 05/16/2002 | US20020058318 Gels for encapsulation of biological materials |
| 05/16/2002 | US20020058317 Process for the fusion of dendritic cells with abnormal tissue cells, in particular tumor cells and media for such a process |
| 05/16/2002 | US20020058064 Flavored gelatin capsule and method of manufacture |
| 05/16/2002 | US20020058046 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 05/16/2002 | US20020058045 Constructing a fiber-mutant adenovirus vector by introducing a foreign peptide into the HI loop of the fiber of the virus. |
| 05/16/2002 | US20020058025 Stromal cell use |
| 05/16/2002 | US20020058023 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells. |
| 05/16/2002 | US20020058019 Simultaneous stimulation and concentration of cells |
| 05/16/2002 | DE10056136A1 Inhibiting leukocyte or tumor cell adhesion to vascular endothelial cells e.g. for combating inflammation or metastasis, using e.g. pregnancy proteins or selectin binding liposomes containing calcium-binding compound |
| 05/16/2002 | DE10054257A1 Medicament for treating osteoarthritis by intraarticular injection, containing plasma as synovial fluid replacement, preferably together with pentosan polysulfate, alpha-tocopherol and phospholipid |
| 05/16/2002 | CA2431997A1 Method of identifying antibacterial compounds |
| 05/16/2002 | CA2428370A1 Compositions and methods for reducing the amount of salmonella in livestock |
| 05/16/2002 | CA2428176A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 05/16/2002 | CA2428145A1 Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
| 05/16/2002 | CA2428141A1 Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis of inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseases |
| 05/16/2002 | CA2427380A1 Resin based on polystyrene functionalised by methyl ester groups of l-tyrosine and their uses |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2425980A1 Foggy |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1204870A2 Method for determining physiological effects of hemoglobin |
| 05/15/2002 | EP1204761A2 Targeted artificial gene delivery |
| 05/15/2002 | EP1204745A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP1204655A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 05/15/2002 | EP1204418A1 Compositions containing muscle-derived active agents |
| 05/15/2002 | EP1204321A2 Super-active porcine growth hormone releasing hormone analog |
| 05/15/2002 | EP1147186A4 In vitro activated gamma delta lymphocytes |
| 05/15/2002 | EP1096941A4 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 05/15/2002 | EP1019067A4 Methods of using emu oil and active fractions thereof as an insect repellent |
| 05/15/2002 | EP0792163B1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/15/2002 | CN2491019Y Heating Bodiyu health and anti-cancer textile products |
| 05/15/2002 | CN1348989A rhamnose lactic acid bacteria strain and its use |
| 05/15/2002 | CN1348811A Women's beautifying health care medicine |
| 05/15/2002 | CN1348809A Dressed plaster for treating Bell's palsy and its prepn |
| 05/15/2002 | CN1348796A Pain treating composite medicine |
| 05/15/2002 | CN1348788A Medicine for treating chronic pharyngitis and its prepn |
| 05/15/2002 | CN1348787A Chinese medicine prepn for treating lupus erythematosus |
| 05/15/2002 | CN1348781A Pulmonotis treating Chinese medicine powder |
| 05/15/2002 | CN1348780A Externally applied medicine powder for treating hyperosteogeny in neck and waist |
| 05/15/2002 | CN1348771A Active animal protein liquid and its application |
| 05/15/2002 | CN1348770A Medicine for preventing newborn baby's stomatitis |
| 05/15/2002 | CN1348769A Lubricating fluid for sexual intercourse |
| 05/15/2002 | CN1348768A 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 05/15/2002 | CN1084628C Bezoar mux vomica powder medicine for treating rabies |
| 05/15/2002 | CN1084626C Granulated prepn for promoting blood-circulation and removing blood stasis |
| 05/15/2002 | CN1084625C Medicine for treating phthalmopathy |
| 05/15/2002 | CN1084624C Food for improving liver function |
| 05/15/2002 | CN1084612C Viracidal, bactericidal and spermicidal veginal suppository |
| 05/14/2002 | US6387943 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 05/14/2002 | US6387701 Method of identifying tumor antigens that elicit a T-cell response |
| 05/14/2002 | US6387693 Cells having ability to form extracellular cartilage matrix are brought into a cell space where they settle on a plate in a culture medium for producing extracellular cartilage matrix |
| 05/14/2002 | US6387612 Method of preparing a terminally heat sterilized plasma-like solution |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387374 Complex consists essentially of a heat shock protein noncovalently bound to an antigenic molecule |
| 05/14/2002 | US6387369 Cardiac muscle regeneration using mesenchymal stem cells |
| 05/14/2002 | US6387367 Human mesenchymal stem cells |
| 05/14/2002 | US6387366 Reducing the biological activity of tissue factor, tf; bone marrow cells; antisense oligonucleotide or ribozyme which inhibits expression of tissue factor (tf) or an antibody that binds to and inhibits tf |
| 05/14/2002 | CA2144601C Recombinant type ii collagenase from clostridium histolyticum and its use for isolating cells and groups of cells |
| 05/14/2002 | CA2104678C Protein-induced morphogenesis |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036751A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 05/10/2002 | WO2002036748A2 Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells |
| 05/10/2002 | WO2002036170A2 Vector system for transducing the positive neurons |
| 05/10/2002 | WO2002036167A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 05/10/2002 | WO2002036156A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 05/10/2002 | WO2002036146A2 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 05/10/2002 | WO2002036141A2 Method of enhancing lymphocyte-mediated immune responses |
| 05/10/2002 | WO2002036137A1 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |
| 05/10/2002 | WO2002036136A2 Compositions and methods for prolonging survival of chilled platelets |
| 05/10/2002 | WO2002036131A1 In vivo stimulation of angiogenic activity |
| 05/10/2002 | WO2002035992A2 Tissue-engineered vascular structures |
| 05/10/2002 | WO2002014479A3 Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells |
| 05/10/2002 | WO2001092477A3 Three-dimensional skin model |
| 05/10/2002 | WO2001090316A3 Human circulating dendritic cell compositions and methods |
| 05/10/2002 | WO2001088116A3 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 05/10/2002 | WO2001085185A3 Treatment of il-10 deficiencies |
| 05/10/2002 | WO2001083750A3 Dendritic cell co-stimulator molecules |
| 05/10/2002 | WO2001083711A3 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 05/10/2002 | WO2001079469A3 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
| 05/10/2002 | WO2001068677A3 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 05/10/2002 | WO2001068135A3 Compositions and methods for affecting osteogenesis |
| 05/10/2002 | WO2001057234A3 Biopolymer thickener |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001047962A3 Attenuated microorganisms for the treatment of infection |